PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma
PLEK2 和 IFI6 分别代表间质和免疫抑制性微环境，可预测食管鳞状细胞癌对新辅助免疫疗法的耐药性。
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-022-03288-0
Liu, Jianhua; Chen, Hao; Qiao, Guibin; Zhang, Jia-Tao; Zhang, Shuaitong; Zhu, Changbin; Chen, Yu; Tang, Jiming; Li, Weiwei; Wang, Siyun; Tian, Hongxia; Chen, Zhihong; Ma, Dong; Tian, Jie; Wu, Yi-Long
